StockData
Anika Therapeutics, Inc. logo

Anika Therapeutics, Inc. (ANIK) stock

ANIKNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/30
$12.85−0.07 (-0.54%)

Close on Nov 17, 2026Market cap $171.97MP/E –Yield –

Anika Therapeutics total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Anika Therapeutics's total debt was $25.00M at Sep 30, 2020. For fiscal 2019 it was $0, down 100.0% from the year before.

Annual total debt

PeriodPeriod endValueChange
FY2019Dec 31, 2019$0-100.0%
FY2012Dec 31, 2012$9.60M-14.3%
FY2011Dec 31, 2011$11.20M-12.5%
FY2010Dec 31, 2010$12.80M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2020Sep 30, 2020$25.00M–
Q2 FY2020Jun 30, 2020$50.00M–
Q4 FY2019Dec 31, 2019$0–

More Anika Therapeutics figures

See a number that looks wrong?